Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability.

Cell | 2017

Mutations truncating a single copy of the tumor suppressor, BRCA2, cause cancer susceptibility. In cells bearing such heterozygous mutations, we find that a cellular metabolite and ubiquitous environmental toxin, formaldehyde, stalls and destabilizes DNA replication forks, engendering structural chromosomal aberrations. Formaldehyde selectively depletes BRCA2 via proteasomal degradation, a mechanism of toxicity that affects very few additional cellular proteins. Heterozygous BRCA2 truncations, by lowering pre-existing BRCA2 expression, sensitize to BRCA2 haploinsufficiency induced by transient exposure to natural concentrations of formaldehyde. Acetaldehyde, an alcohol catabolite detoxified by ALDH2, precipitates similar effects. Ribonuclease H1 ameliorates replication fork instability and chromosomal aberrations provoked by aldehyde-induced BRCA2 haploinsufficiency, suggesting that BRCA2 inactivation triggers spontaneous mutagenesis during DNA replication via aberrant RNA-DNA hybrids (R-loops). These findings suggest a model wherein carcinogenesis in BRCA2 mutation carriers can be incited by compounds found pervasively in the environment and generated endogenously in certain tissues with implications for public health.

Pubmed ID: 28575672 RIS Download

Antibodies used in this publication

Associated grants

  • Agency: Medical Research Council, United Kingdom
    Id: G1001521
  • Agency: Medical Research Council, United Kingdom
    Id: G1001522
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UU_12022/1
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UU_12022/8

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


ATCC (tool)

RRID:SCR_001672

Global nonprofit biological resource center (BRC) and research organization that provides biological products, technical services and educational programs to private industry, government and academic organizations. Its mission is to acquire, authenticate, preserve, develop and distribute biological materials, information, technology, intellectual property and standards for the advancement and application of scientific knowledge. The primary purpose of ATCC is to use its resources and experience as a BRC to become the world leader in standard biological reference materials management, intellectual property resource management and translational research as applied to biomaterial development, standardization and certification. ATCC characterizes cell lines, bacteria, viruses, fungi and protozoa, as well as develops and evaluates assays and techniques for validating research resources and preserving and distributing biological materials to the public and private sector research communities.

View all literature mentions

Novus Biologicals (tool)

RRID:SCR_004286

Commercial antibody vendor which supplies antibodies and other products to life science researchers.

View all literature mentions

ProteomeXchange (tool)

RRID:SCR_004055

A data repository for proteomic data sets. The ProteomeExchange consortium, as a whole, aims to provide a coordinated submission of MS proteomics data to the main existing proteomics repositories, as well as to encourage optimal data dissemination. ProteomeXchange provides access to a number of public databases, and users can access and submit data sets to the consortium's PRIDE database and PASSEL/PeptideAtlas.

View all literature mentions

PeproTech (tool)

RRID:SCR_006802

An Antibody supplier

View all literature mentions

Program to Reduce Incontinence by Diet and Exercise (tool)

RRID:SCR_009018

Randomized controlled trial being conducted at two clinical centers in the United States to learn more about the effects of weight loss on urinary incontinence. About 330 overweight women aged 30 or older will participate and will be followed for 18 months. Efficacy of weight reduction as a treatment for urinary incontinence will be examined at 6 months following the intensive weight control program, and the sustained impact of the intervention will be examined at 18 months. To increase the maintenance of weight reduction and facilitate evaluation of the enduring impact of weight loss on urinary incontinence, they propose to study a motivation-based weight maintenance program. At the end of the intensive weight control program, women randomized to the weight loss program will be randomized to either a 12-month skill-based maintenance intervention or to a motivation-based maintenance intervention. The maintenance interventions maximize the potential for sustained weight loss and will allow them to determine if long-term weight reduction will produce continued improvement in urinary incontinence.

View all literature mentions

Bethyl (tool)

RRID:SCR_013554

An Antibody supplier

View all literature mentions

HeLa (tool)

RRID:CVCL_0030

Cell line HeLa is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions

JAK1 Antibody (B-3) (antibody)

RRID:AB_2687564

This monoclonal targets JAK1

View all literature mentions

ATR (phospho Thr1989) antibody (antibody)

RRID:AB_2687562

This polyclonal targets ATR (phospho Thr1989)

View all literature mentions

PLK1 Antibody Cocktail (antibody)

RRID:AB_2533104

This cocktail targets PLK1

View all literature mentions

c-Myc Antibody (9E10) (antibody)

RRID:AB_627268

This monoclonal targets c-Myc

View all literature mentions

mCherry Antibody (antibody)

RRID:AB_11034849

This monoclonal targets mCherry

View all literature mentions

XRCC4-human (antibody)

RRID:AB_301278

This polyclonal targets XRCC4

View all literature mentions

Ku70 antibody [N3H10] (antibody)

RRID:AB_2219041

This monoclonal targets Ku70

View all literature mentions

Ku-86 (M-20) (antibody)

RRID:AB_2288756

This polyclonal targets XRCC5

View all literature mentions

FANCI antibody (antibody)

RRID:AB_443182

This polyclonal targets FANCI antibody

View all literature mentions

Anti-XRCC3 Rabbit pAb (antibody)

RRID:AB_2304699

This polyclonal targets XRCC3

View all literature mentions

Anti-β-Actin Antibody (antibody)

RRID:AB_476744

This monoclonal targets slightly modified β-cytoplasmic actin N-terminal peptide, Ac-Asp-Asp-Asp-Ile-Ala-Ala-Leu-Val-Ile-Asp-Asn-Gly-Ser-Gly-Lys, conjugated to KLH

View all literature mentions

Mono- and polyubiquitinylated conjugates, mAb (FK2) (antibody)

RRID:AB_10541840

This monoclonal targets Mono- and polyubiquitinylated conjugates mAb (FK2)

View all literature mentions

LC3B (D11) XP Rabbit mAb (antibody)

RRID:AB_2137707

This monoclonal targets LC3B (D11) XP Rabbit mAb

View all literature mentions

Monoclonal Anti-ATM antibody produced in mouse (antibody)

RRID:AB_796190

This monoclonal targets ATM antibody produced in mouse

View all literature mentions

ATM (phospho S1981) antibody [EP1890Y] (antibody)

RRID:AB_1640207

This monoclonal targets ATM, phospho (Ser1981)

View all literature mentions

Rad51 antibody [14B4] (antibody)

RRID:AB_372856

This monoclonal targets Rad51

View all literature mentions

PALB2 Antibody (antibody)

RRID:AB_890607

This unknown targets PALB2

View all literature mentions

BRCA1 (C-20) (antibody)

RRID:AB_630944

This polyclonal targets BRCA1

View all literature mentions

BrdU (antibody)

RRID:AB_10015219

This unknown targets BrdU

View all literature mentions

hTERT-RPE1 (cell line)

RRID:CVCL_4388

Cell line hTERT-RPE1 is a Telomerase immortalized cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MCF-7 (cell line)

RRID:CVCL_0031

Cell line MCF-7 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MCF-10A (cell line)

RRID:CVCL_0598

Cell line MCF-10A is a Spontaneously immortalized cell line with a species of origin Homo sapiens

View all literature mentions

U2OS (cell line)

RRID:CVCL_0042

Cell line U2OS is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

Image Studio Lite (software resource)

RRID:SCR_013715

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 28,2023. Software application which can analyze basic Western blot data and export them for use in spreadsheet programs. Users can create standardized or custom lab reports and can share them with colleagues. Image Studio Lite has been discontinued and replaced with Empiria Studio Software.

View all literature mentions

R Project for Statistical Computing (software resource)

RRID:SCR_001905

Software environment and programming language for statistical computing and graphics. R is integrated suite of software facilities for data manipulation, calculation and graphical display. Can be extended via packages. Some packages are supplied with the R distribution and more are available through CRAN family.It compiles and runs on wide variety of UNIX platforms, Windows and MacOS.

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions